Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study

Abstract Background Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. Methods This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors assoc...

Full description

Saved in:
Bibliographic Details
Published inOpen forum infectious diseases Vol. 10; no. 8; p. ofad400
Main Authors Hanna, John J, Geresu, Liyu B, Diaz, Marlon I, Ho, Milan, Casazza, Julia A, Pickering, Madison A, Lanier, Heather D, Radunsky, Alexander P, Cooper, Lauren N, Saleh, Sameh N, Bedimo, Roger J, Most, Zachary M, Perl, Trish M, Lehmann, Christoph U, Turer, Robert W, Chow, Jeremy Y, Medford, Richard J
Format Journal Article
LanguageEnglish
Published US Oxford University Press 01.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. Methods This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors associated with SARS-CoV-2 positivity among PWH and risk factors for severe outcomes, including hospitalization, intensive care unit stays, and death. A subset analysis was conducted to examine HIV-specific variables. Multiple variable logistic regression was used to adjust for covariates. Results Of 43 173 PWH included in this study, 6472 had a positive SARS-CoV-2 result based on a polymerase chain reaction test or antigen test. For PWH with SARS-CoV-2 positivity, higher odds were found for those who were younger (18–49 years), Hispanic White, African American, from the US South, uninsured, and a noncurrent smoker and had a higher body mass index and higher Charlson Comorbidity Index. For PWH with severe outcomes, higher odds were identified for those who were SARS-CoV-2 positive, older, from the US South, receiving Medicaid/Medicare or uninsured, a current smoker, and underweight and had a higher Charlson Comorbidity Index. In a subset analysis including PWH with HIV care variables (n = 5098), those with unsuppressed HIV viral load, a low CD4 count, and no antiretroviral therapy had higher odds of severe outcomes. Conclusions This large US study found significant ethnic, racial, and geographic differences in SARS-CoV-2 infection among PWH. Chronic comorbidities, older age, lower body mass index, and smoking were associated with severe outcomes among PWH during the COVID-19 pandemic. SARS-CoV-2 infection was associated with severe outcomes, but once we adjusted for HIV care variables, SARS-CoV-2 was no longer significant; however, low CD4 count, high viral load, and lack of antiretroviral therapy had higher odds of severe outcomes. People with HIV and SARS-CoV-2 were more likely to be young, Hispanic White or African American, Southern, uninsured, and overweight and have comorbidities. People with HIV who had worse outcomes were older, uninsured, underweight, and a current smoker and had comorbidities, unsuppressed viral load, low CD4 count, and no antiretroviral therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Potential conflicts of interest . J. Y. C. has received an investigator-initiated grant from Gilead Sciences for a project unrelated to the topic of this article. R. J. M. is funded through the Texas Health Resources Clinical Scholar Program and the Centers for Disease Control and Prevention (grant U01CK000590) and has received research funding through Verily Life Sciences and the Sergey Brin Family Foundation. All other authors report no potential conflicts.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofad400